Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Medifast Q2 expected to be more than $(0.55) vs $(0.08) Est; Sees Q2 Sales $85.000M-$105.000M vs $111.20M Est

Author: Benzinga Newsdesk | April 28, 2025 04:22pm
Medifast (NYSE:MED) Q2 expected to be more than $(0.55) vs $(0.08) Est. sees Q2 sales of $85.000 million-$105.000 million vs $111.20 million analyst estimate.

Posted In: MED


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist